Disproportionality methods for pharmacovigilance in longitudinal observational databases
- PMID: 21878461
- DOI: 10.1177/0962280211403602
Disproportionality methods for pharmacovigilance in longitudinal observational databases
Abstract
Data mining disproportionality methods (PRR, ROR, EBGM, IC, etc.) are commonly used to identify drug safety signals in spontaneous report system (SRS) databases. Newer data sources such as longitudinal observational databases (LOD) provide time-stamped patient-level information and overcome some of the SRS limitations such as an absence of the denominator, total number of patients who consume a drug, and limited temporal information. Application of the disproportionality methods to LODs has not been widely explored. The scale of the LOD data provides an interesting computational challenge. Larger health claims databases contain information on more than 50 million patients and each patient has records for up to 10 years. In this article we systematically explore the application of commonly used disproportionality methods to simulated and real LOD data.
Similar articles
-
Signal detection of methylphenidate by comparing a spontaneous reporting database with a claims database.Regul Toxicol Pharmacol. 2011 Nov;61(2):154-60. doi: 10.1016/j.yrtph.2011.03.015. Epub 2011 Apr 9. Regul Toxicol Pharmacol. 2011. PMID: 21510997
-
Safety of antipsychotic drugs: A systematic review of disproportionality analysis studies.Behav Brain Res. 2021 Apr 23;404:113168. doi: 10.1016/j.bbr.2021.113168. Epub 2021 Feb 10. Behav Brain Res. 2021. PMID: 33581145
-
Multiple self-controlled case series for large-scale longitudinal observational databases.Biometrics. 2013 Dec;69(4):893-902. doi: 10.1111/biom.12078. Epub 2013 Oct 11. Biometrics. 2013. PMID: 24117144
-
Pharmacovigilance systems and databases in Korea, Japan, and Taiwan.Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1237-45. doi: 10.1002/pds.2244. Epub 2011 Sep 21. Pharmacoepidemiol Drug Saf. 2011. PMID: 21936017 Review.
-
A shrinkage-based comparative assessment of observed-to-expected disproportionality measures.Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):589-96. doi: 10.1002/pds.2349. Epub 2012 Jan 30. Pharmacoepidemiol Drug Saf. 2012. PMID: 22290739
Cited by
-
Comparative Pharmacovigilance Analysis of Approved and Repurposed Antivirals for COVID-19: Insights from EudraVigilance Data.Biomedicines. 2025 Jun 5;13(6):1387. doi: 10.3390/biomedicines13061387. Biomedicines. 2025. PMID: 40564106 Free PMC article.
-
Adverse events following 9-valent human papillomavirus vaccine (GARDASIL® 9) reported to the Vaccine Adverse Event Reporting System (VAERS), 2015-2024.Hum Vaccin Immunother. 2025 Dec;21(1):2530831. doi: 10.1080/21645515.2025.2530831. Epub 2025 Jul 15. Hum Vaccin Immunother. 2025. PMID: 40662677 Free PMC article.
-
A New Search Method Using Association Rule Mining for Drug-Drug Interaction Based on Spontaneous Report System.Front Pharmacol. 2018 Mar 9;9:197. doi: 10.3389/fphar.2018.00197. eCollection 2018. Front Pharmacol. 2018. PMID: 29593533 Free PMC article.
-
Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?Clin Drug Investig. 2017 May;37(5):415-422. doi: 10.1007/s40261-017-0503-6. Clin Drug Investig. 2017. PMID: 28224371 Review.
-
Digital monitoring of medication safety in children: an investigation of ADR signalling techniques in Malaysia.BMC Med Inform Decis Mak. 2024 Dec 18;24(1):395. doi: 10.1186/s12911-024-02801-y. BMC Med Inform Decis Mak. 2024. PMID: 39695558 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources